Showing 1 - 6 results of 6 for search 'Hans Gelderblom', query time: 0.02s Refine Results
  1. 1
    Dynamic prediction of overall survival: a retrospective analysis on 979 patients with Ewing sarcoma from the German registry

    Dynamic prediction of overall survival: a retrospective analysis on 979 patients with Ewing sarcoma from the German registry by Hans Gelderblom, Marta Fiocco, Chuchu Liu, Anja J Rueten-Budde, Andreas Ranft, Uta Dirksen

    Published 2020-10-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    The Impact of Chemotherapy and Body Mass Index on Cancer‐Related Fatigue in Colon Cancer Patients: A PROFILES‐Registry Study

    The Impact of Chemotherapy and Body Mass Index on Cancer‐Related Fatigue in Colon Cancer Patients: A PROFILES‐Registry Study by Anneke Kastelein, Floortje Mols, Laura Kervezee, Niels H. Chavannes, Hans Gelderblom, Jacques Neefjes, Chris Hinnen

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Novel longitudinal Multiple Overall Toxicity (MOTox) score to quantify adverse events experienced by patients during chemotherapy treatment: a retrospective analysis of the MRC BO06 trial in osteosarcoma

    Novel longitudinal Multiple Overall Toxicity (MOTox) score to quantify adverse events experienced by patients during chemotherapy treatment: a retrospective analysis of the MRC BO0... by Jakob Anninga, Hans Gelderblom, Marta Fiocco, Marta Spreafico, Francesca Ieva, Francesca Arlati, Federico Capello, Federico Fatone, Filippo Fedeli, Gianmarco Genalti

    Published 2021-12-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Levels of circulating tumor DNA correlate with tumor volume in gastro‐intestinal stromal tumors: an exploratory long‐term follow‐up study

    Levels of circulating tumor DNA correlate with tumor volume in gastro‐intestinal stromal tumors: an exploratory long‐term follow‐up study by Roos F. Bleckman, Charlotte M. S. C. Haag, Naomi Rifaela, Gerrieke Beukema, Ron H. J. Mathijssen, Neeltje Steeghs, Hans Gelderblom, Ingrid M. E. Desar, Arjen Cleven, Arja terElst, Ed Schuuring, Anna K. L. Reyners

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Long-term survival of participants in the PASART-1 and PASART-2 trials of neo-adjuvant pazopanib and radiotherapy in soft tissue sarcoma

    Long-term survival of participants in the PASART-1 and PASART-2 trials of neo-adjuvant pazopanib and radiotherapy in soft tissue sarcoma by Bauke H.G. van Riet, Milan van Meekeren, Marta Fiocco, Aisha Miah, Ilse de Pree, Lisette M. Wiltink, Astrid Scholten, Lotte Heimans, Judith V.M.G. Bovée, Hans Gelderblom, Neeltje Steeghs, Rick L. Haas

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors

    A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors by Hans Gelderblom, Patrick M Forde, Aung Naing, Matthew Taylor, Jennifer Mataraza, Marcus O Butler, Todd M Bauer, Justin F Gainor, Chia-Chi Lin, Sunil Sharma, Maria Ochoa de Olza, Andrea Varga, Jan H M Schellens, Hongqian Wu, Haiying Sun, Antonio P Silva, Jason Faris, Scott Cameron

    Published 2020-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: